Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Lachmann

Showing results (211-220 of 287) with videos related to

Pageof 29
Sort By:
Arthritis and Rheumatism|September 1, 1987
Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosusF Moldenhauer, J David, A H Fielder, et al.
Immunology|January 1, 1973
Studies on the terminal stages of complement lysisP J Lachmann, D E Bowyer, P Nicol, et al.
Journal of Immunological Methods|June 18, 1993
A competitive inhibition ELISA for the quantification of human interferon-gammaA B Wilson, S M McHugh, J Deighton, et al.
Clinical and Experimental Immunology|September 1, 1996
CR1 stump peptide and terminal complement complexes are found in the glomeruli of lupus nephritis patientsJ E Teixeira, R S Costa, P J Lachmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1995
Molecular basis of the complement C7 M/N polymorphism. A neutral amino acid substitution outside the epitope of the allospecific monoclonal antibody WU 4-15R Würzner, B A Fernie, A M Jones, et al.
The Journal of Clinical Investigation|June 1, 1974
Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemiaJ A Charlesworth, D G Williams, E Sherington, et al.
The Journal of Clinical Investigation|March 1, 1975
Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiencyJ B Ziegler, C A Alper, R S Rosen, et al.
Allergy|October 1, 1994
The profiles of interleukin (IL)-2, IL-6, and interferon-gamma production by peripheral blood mononuclear cells from house-dust-mite-allergic patients: a role for IL-6 in allergic diseaseS M McHugh, A B Wilson, J Deighton, et al.
Immunology|May 1, 1992
Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59M G Wing, J Zajicek, D J Seilly, et al.
Clinical and Experimental Immunology|March 1, 1974
Metabolism of radio-labelled C3: effects of in vivo activation in rabbitsJ A Charlesworth, D G Williams, P Naish, et al.
Pageof 29

Showing results (211-220 of 287) with videos related to

Sort By:
Pageof 29
Arthritis and Rheumatism|September 1, 1987
Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosusF Moldenhauer, J David, A H Fielder, et al.
Immunology|January 1, 1973
Studies on the terminal stages of complement lysisP J Lachmann, D E Bowyer, P Nicol, et al.
Journal of Immunological Methods|June 18, 1993
A competitive inhibition ELISA for the quantification of human interferon-gammaA B Wilson, S M McHugh, J Deighton, et al.
Clinical and Experimental Immunology|September 1, 1996
CR1 stump peptide and terminal complement complexes are found in the glomeruli of lupus nephritis patientsJ E Teixeira, R S Costa, P J Lachmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1995
Molecular basis of the complement C7 M/N polymorphism. A neutral amino acid substitution outside the epitope of the allospecific monoclonal antibody WU 4-15R Würzner, B A Fernie, A M Jones, et al.
The Journal of Clinical Investigation|June 1, 1974
Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemiaJ A Charlesworth, D G Williams, E Sherington, et al.
The Journal of Clinical Investigation|March 1, 1975
Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiencyJ B Ziegler, C A Alper, R S Rosen, et al.
Allergy|October 1, 1994
The profiles of interleukin (IL)-2, IL-6, and interferon-gamma production by peripheral blood mononuclear cells from house-dust-mite-allergic patients: a role for IL-6 in allergic diseaseS M McHugh, A B Wilson, J Deighton, et al.
Immunology|May 1, 1992
Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59M G Wing, J Zajicek, D J Seilly, et al.
Clinical and Experimental Immunology|March 1, 1974
Metabolism of radio-labelled C3: effects of in vivo activation in rabbitsJ A Charlesworth, D G Williams, P Naish, et al.
Pageof 29